Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Guidance Documents/Program/Chapter 48 7348809A Radioactive Drug Research Committee

Chapter 48 7348809A Radioactive Drug Research Committee

Detailed guidance document from FDA and regulatory agencies.

Document Details

Document Type

Program

Issue Date

April 16, 2018

Last Updated

December 1, 2018

Office

Office of Regulatory Affairs

Document ID

bfb941da-2647-409d-bbc4-1bdb2311eaf4

Related Documents

CDER CDRH Combo Product Compliance Program

ProgramJune 4, 2020Center for Biologics Evaluation and Research

View Details →

CHAPTER 48 - 7348809 Bioresearch Monitoring

ProgramApril 4, 2025Office of Regulatory Affairs

View Details →

Final In Vivo Bioavailability-Bioequivalence Studies- Analytical

ProgramMay 1, 2018Office of Regulatory Affairs

View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

Regulatory Data Transformed

Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

Home Platform Overview Media

KeyPedia™ Lite

Browse Hub Database Directory Records Companies Offices People Careers About Us Founding Team Meet Our Experts Partners

Legal & Ethics

Privacy Policy Terms of Service Our Values & Mission Code of Ethics & AI Policy

©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.

Chapter 48 7348809A Radioactive Drug Research Committee - FDA Guidance Document | KeyPedia